The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
127112522 12711252 2 F 20160729 20160830 20160902 20160913 EXP US-ASTRAZENECA-2016SE92463 ASTRAZENECA 20685.00 DY F Y 57.60000 KG 20160914 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
127112522 12711252 1 PS ARIMIDEX ANASTROZOLE 1 Oral 20541 1 MG TABLET QD
127112522 12711252 2 SS ARIMIDEX ANASTROZOLE 1 Oral 20541 1 MG TABLET QD
127112522 12711252 3 SS CRESTOR ROSUVASTATIN CALCIUM 1 Oral 10.0MG UNKNOWN Y U 0 10 MG TABLET
127112522 12711252 4 SS LIPITOR ATORVASTATIN CALCIUM 1 Oral 40 MG HALF TABLET BY MOUTH ONCE DAILY. ON THE 3RD WEEK SHE WAS TO TAKE A WHOLE TABLE DAILY. Y U 0 TABLET
127112522 12711252 5 SS PREDNISONE. PREDNISONE 1 Oral Y 0 10 MG TABLET TID
127112522 12711252 6 C BAYER ASPIRIN ASPIRIN 1 Oral 81MG 2 TABLETS BY MOUTH DAILY, STARTED ABOUT 10 YEARS AGO 0 TABLET
127112522 12711252 7 C VITAMIN D CHOLECALCIFEROL 1 Oral 5000 IU TWO TABLETS BY MOUTH DAILY 0 TABLET
127112522 12711252 8 C VITAMIN D CHOLECALCIFEROL 1 Oral 5000 IU TWO TABLETS BY MOUTH DAILY 0 TABLET
127112522 12711252 9 C OMEGA 3 FISH OIL FISH OILOMEGA-3 FATTY ACIDS 1 Oral 1000 MG, TWO LIQUIGELS BY MOUTH DAILY 0
127112522 12711252 10 C TAXIDERA 2 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
127112522 12711252 1 Breast cancer
127112522 12711252 2 Neoplasm malignant
127112522 12711252 3 Blood cholesterol abnormal
127112522 12711252 4 Blood cholesterol abnormal
127112522 12711252 6 Anticoagulant therapy
127112522 12711252 7 Vitamin D deficiency
127112522 12711252 8 Neoplasm malignant
127112522 12711252 9 Blood triglycerides

Outcome of event

Event ID CASEID OUTC COD
127112522 12711252 HO
127112522 12711252 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
127112522 12711252 Abdominal discomfort
127112522 12711252 Blood cholesterol increased
127112522 12711252 Brain oedema
127112522 12711252 Breast cancer
127112522 12711252 Confusional state
127112522 12711252 Diarrhoea
127112522 12711252 Dizziness
127112522 12711252 High density lipoprotein decreased
127112522 12711252 Hyperhidrosis
127112522 12711252 Low density lipoprotein increased
127112522 12711252 Movement disorder
127112522 12711252 Muscle spasms
127112522 12711252 Myalgia
127112522 12711252 Nausea
127112522 12711252 Night sweats
127112522 12711252 Speech disorder
127112522 12711252 Swelling
127112522 12711252 Vomiting

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
127112522 12711252 1 20150218 0
127112522 12711252 2 20150218 0
127112522 12711252 4 20160729 20160823 0
127112522 12711252 7 2014 0
127112522 12711252 8 2014 0
127112522 12711252 9 2015 0